Caveolin-1-positive CAFs are able to remodel tumor microenvironments in vivo, facilitating tumor invasion and increasing metastatic potential, which correlates with low survival in breast cancer and with other clinicopathologic variables, such as pleural invasion, shorter recurrence and predominantly solid subtypes in lung cancer (23). This evidence concerns the gene CAV1 and breast carcinoma.